Infinera Corporation (NASDAQ: INFN) today released financial results for its third quarter ended September 28, 2024. GAAP revenue for the quarter was ...
Q4 2024 Earnings Call Transcript November 2, 2024 Operator: Good day, and welcome to the S&W Seed Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Higher third quarter funds flow from operations of $124.7 million ($1.64 per share) — a 34 percent increase over the third quarter of 2023 on a per share basis 2024 average production expected to be ...
Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...